NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Nucleotide-binding domain, leucine-rich repeat containing receptors (NLRs) function as pattern recognition receptors, crucial for innate immunity.
• NLRs detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), initiating inflammatory responses.
• Dysregulation of NLRs is implicated in various diseases, including cancer, metabolic disorders, and autoimmune conditions.

Purpose of the Study:

• To review the current understanding of NLRs' roles in cancer initiation, development, and progression.
• To explore the controversial and emerging functions of NLRs within the tumor microenvironment.
• To discuss the potential of NLRs as therapeutic targets for cancer treatment.

Main Methods:

• Literature review of peer-reviewed studies on NLRs and cancer.
• Analysis of experimental and clinical data regarding NLR expression and function in various cancers.
• Synthesis of findings to present a comprehensive overview of NLRs in oncology.

Main Results:

• NLRs exhibit diverse and context-dependent roles in cancer, acting as both tumor suppressors and promoters.
• Specific NLRs have been identified to influence immune surveillance, inflammation, and cellular processes critical to tumorigenesis.
• Evidence suggests that targeting NLR pathways could modulate anti-tumor immunity and cancer cell behavior.

Conclusions:

• The role of NLRs in cancer is complex and multifaceted, requiring further investigation.
• NLRs represent promising targets for novel cancer therapeutics, potentially enhancing existing treatment strategies.
• Future research should focus on elucidating cell- and organ-specific functions of NLRs to optimize therapeutic applications.